Monday, July 13, 2026

The European Medicines Agency (EMA)

July 19, 2022

AstraZeneca’s Enhertu gets EU approval to treat breast cancer

AstraZeneca and Daiichi Sankyo’s drug, Enhertu, has been approved by the European Union for treatment of adult patients with an aggressive form of breast cancer.